TGA provisionally approves Pfizer booster shots for Australian adults

TGA provisionally approves Pfizer booster shots for Australian adults

The Therapeutic Goods Administration (TGA) has today provisionally approved a booster dose of the Pfizer COVID-19 vaccine (COMIRANTY) for Australians aged 18 years and older.

The provisional approval means adults may receive a booster shot (third dose) of the Pfizer vaccine at least six months after being fully vaccinated, even if the first two doses were AstraZeneca or Moderna shots.

In addition, consistent with Australian Technical Advisory Group on Immunisation (ATAGI) advice, the TGA says a third dose may be given to severely immunocompromised people aged 12 years and over at least 28 days after the second dose.

“TGA provisionally approved the booster dose following careful evaluation of the available data supporting safety and efficacy,” the TGA said.

“The TGA's decision was also informed by expert advice from the Advisory Committee on Vaccines, an independent committee with scientific, clinical and consumer representation.

“The Australian Government's priority continues to be completion of a two-dose vaccination schedule as this enables strong protection against severe illness and hospitalisation. Further information on the vaccine roll out will subsequently be published on the Department of Health's website.”

Updated at 9.32am AEDT on 27 October 2021.

Enjoyed this article?

Don't miss out on the knowledge and insights to be gained from our daily news and features.

Subscribe today to unlock unlimited access to in-depth business coverage, expert analysis, and exclusive content across all devices.

Support independent journalism and stay informed with stories that matter to you.

Subscribe now and get 50% off your first year!

Four time-saving tips for automating your investment portfolio
Partner Content
In today's fast-paced investment landscape, time is a valuable commodity. Fortunately, w...
Etoro
Advertisement

Related Stories

HESTA to pump $250m into new global fund with Stafford Capital Partners

HESTA to pump $250m into new global fund with Stafford Capital Partners

Strong returns over the past three years from a $200 million global...

Breakthrough Victoria up to the test with $15m investment in Liquid Instruments

Breakthrough Victoria up to the test with $15m investment in Liquid Instruments

A Canberra-born, San Diego-headquartered technology company that re...

Pacific Smiles to extend nib dental offering to all centres

Pacific Smiles to extend nib dental offering to all centres

Takeover target Pacific Smiles (ASX: PSQ) may see its clinics filli...

The Chemist Warehouse deal is a sideshow: pharmacies are ripe for bigger disruption

The Chemist Warehouse deal is a sideshow: pharmacies are ripe for bigger disruption

There’s something curious about the proposed merger between C...